RARA CRAFT DATABASE for FDA Medical Devices
De NovoDEN070006

FDA DEVICE FACTS

BINAX NOW MALARIA TEST; MODEL 660-000, 6

Inverness Medical Professional Diagnosti

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATE06/13/2007PRODUCT CODEOAX

Indications for use

The Binax NOW® Malaria Test is a prescription device under 21 CFR Part 801.109 that is intended for the qualitative detection of Plasmodium antigens circulating in human venous and capillary EDTA whole blood of individuals with signs and symptoms of malarial infection. The test targets the histidine-rich protein II (HRP2) antigen specific to Plasmodium falciparum and a pan-malarial antigen, common to all four malaria species capable of infecting humans - P. falciparum, P. vivax, P. ovale, and P. malariae. It is intended to aid in the rapid diagnosis of human malaria infections and to aid in the differential diagnosis of Plasmodium falciparum infections from other less virulent malarial infections. Negative results must be confirmed by thin/thick smear microscopy.

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: July 28, 2026